In her 25-year career, Hawker has expertise in directing pan-European and UK medical communications and PR programmes.
Kate joins B-M from the InforMed group of medical communications companies where she was business development director. She held this position for three years since launching the start-up medical communications company Medea, as part of InforMed.
Before setting up Medea, Kate was Director and Partner at Fleishman Hillard which she joined in 2006 when they bought out her shares in The Remedy, the medical communications agency she had founded in 2000, and incorporated it into the FH healthcare practice.
In her career Hawker has worked on campaigns for GSK, Baxter, Takeda, Boehringer, Bristol Myers Squibb, and MSD, among others.